16 Chapter 1 REFERENCE LIST 1. James PD. Women and bleeding disorders: diagnostic challenges. Hematology Am Soc Hematol Educ Program. 2020;2020(1):547-52. 2. Doherty D, Lavin M. Challenges facing women and girls with bleeding disorders. Lancet Haematol. 2023;10(11):e875-e6. 3. Mol BW, Bongers MY, Brolmann HA. Treatment of menorrhagia. Lancet. 2001;357(9271):1886-7. 4. van den Brink MJ, Beelen P, Herman MC, Geomini PM, Dekker JH, Vermeulen KM, et al. The levonorgestrel intrauterine system versus endometrial ablation for heavy menstrual bleeding: a cost-effectiveness analysis. BJOG. 2021;128(12):200311. 5. Herman MC, Mol BW, Bongers MY. Diagnosis of heavy menstrual bleeding. Womens Health (Lond). 2016;12(1):15-20. 6. Weyand AC, James PD. Sexism in the management of bleeding disorders. Res Pract Thromb Haemost. 2021;5(1):51-4. 7. Sanigorska A, Chaplin S, Holland M, Khair K, Pollard D. The lived experience of women with a bleeding disorder: A systematic review. Res Pract Thromb Haemost. 2022;6(1):e12652. 8. Punt MC, Ruigrok ND, Bloemenkamp KWM, Uitslager N, Urbanus RT, Groot E, et al. Prevalence, burden and treatment effects of vaginal bleeding in women with (suspected) congenital platelet disorders throughout life: a cross-sectional study. Br J Haematol. 2022;196(1):215-23. 9. Punt MC, Blaauwgeers MW, Timmer MA, Welsing PMJ, Schutgens REG, van Galen KPM. Reliability and Feasibility of the Self-Administered ISTH-Bleeding Assessment Tool. TH Open. 2019;3(4):e350-e5. 10. Curry N, Lowe G, Clark TJ. Inherited bleeding disorders in heavy menstrual bleeding: The case for joint haematological and gynaecological care. BJOG. 2023;130(5):439-41. 11. Kontogiannis A, Matsas A, Valsami S, Livanou ME, Panoskaltsis T, Christopoulos P. Primary Hemostasis Disorders as a Cause of Heavy Menstrual Bleeding in Women of Reproductive Age. J Clin Med. 2023;12(17). 12. Bongers MY. Second-generation endometrial ablation treatment: Novasure. Best Pract Res Clin Obstet Gynaecol. 2007;21(6):989-94. 13. Bhattacharya S, Middleton LJ, Tsourapas A, Lee AJ, Champaneria R, Daniels JP, et al. Hysterectomy, endometrial ablation and Mirena(R) for heavy menstrual bleeding: a systematic review of clinical effectiveness and cost-effectiveness analysis. Health Technol Assess. 2011;15(19):iii-xvi, 1-252. 14. Rubin G, Wortman M, Kouides PA. Endometrial ablation for von Willebrand disease-related menorrhagia--experience with seven cases. Haemophilia. 2004;10(5):477-82. 15. Rodeghiero F, Tosetto A, Abshire T, Arnold DM, Coller B, James P, et al. ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost. 2010;8(9):2063-5. 16. Jain S, Zhang S, Acosta M, Malone K, Kouides P, Zia A. Prospective evaluation of ISTH-BAT as a predictor of bleeding disorder in adolescents presenting with heavy menstrual bleeding in a multidisciplinary hematology clinic. J Thromb Haemost. 2020;18(10):2542-50. 17. Elbatarny M, Mollah S, Grabell J, Bae S, Deforest M, Tuttle A, et al. Normal range of bleeding scores for the ISTH-BAT: adult and pediatric data from the merging project. Haemophilia. 2014;20(6):831-5. 18. Greenhalgh T. Narrative based medicine: narrative based medicine in an evidence based world. BMJ. 1999;318(7179):323-5. 19. Charon R. The patient-physician relationship. Narrative medicine: a model for empathy, reflection, profession, and trust. JAMA. 2001;286(15):1897902. 20. Parker M, Hannah M, Zia A. “If I wasn’t a girl”: Experiences of adolescent girls with heavy menstrual bleeding and inherited bleeding disorders. Res Pract Thromb Haemost. 2022;6(4):e12727. 21. Kerins J, Smith SE, Tallentire VR. ‘Just pretending’: Narratives of professional identity transitions in internal medicine. Med Educ. 2023;57(7):627-36. 22. Babbar K, Martin J, Varanasi P, Avendano I. Inclusion means everyone: standing up for transgender and non-binary individuals who menstruate worldwide. Lancet Reg Health Southeast Asia. 2023;13:100177.
RkJQdWJsaXNoZXIy MTk4NDMw